The potential role of hematocrit control on symptom burden among polycythemia vera patients: Insights from the CYTO-PV and MPN-SAF patient cohorts

Current guidelines suggest that polycythemia vera (PV) patients maintain a strict hematocrit less than 45%. However, to date, little is known about the relationship between HCT control and PV-related symptom burden. In this study, PV patient data was analyzed from the CYTO PV trial (n = 224) and the...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Leuk Lymphoma
Main Authors: Scherber, Robyn Marie, Geyer, Holly Lynn, Dueck, Amylou C., Kosiorek, Heidi E., Finazzi, Guido, Cavazzina, Riccardo, Masciulli, Arianna, Scarano, Marco, Vannucchi, Alessandro M., Mesa, Ruben A., Barbui, Tiziano
Formato: Artigo
Idioma:Inglês
Publicado: 2016
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8148875/
https://ncbi.nlm.nih.gov/pubmed/27830999
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10428194.2016.1246733
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares